Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
基本信息
- 批准号:10452547
- 负责人:
- 金额:$ 44.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnnexin A1Aortic Valve StenosisAreaBloodCMKLR1 geneCalcium ChannelCellsClinical ResearchDataDiseaseDisease ProgressionEnvironmentExperimental ModelsFamily suidaeGoalsHumanIn VitroInflammation MediatorsInjuryInterruptionInterventionInvestigationMechanicsMediator of activation proteinMedicalModelingMolecularMusPatternPhysiologicalPrevalencePreventive treatmentProcessPropertyResearchResearch SupportResolutionRiskRisk FactorsRoleSignal TransductionStenosisSurfaceSyndromeTherapeuticTissuesTranslationsUp-RegulationVanilloidaortic valveaortic valve disordercalcificationcell injuryclinical translationclinically relevantdesigneffective therapyexperimental studyhemodynamicsin vivoin vivo Modelinnovationinterstitial cellmechanical forcemechanical loadmechanical propertiesmouse modelnovelpre-clinical researchreceptorresponseresponse to injurysensortissue injuryvalve replacement
项目摘要
Project Summary
Calcific aortic valve stenosis (CAVS) can be viewed as the end-stage of prolonged persistent injury in valve
tissue. Isolated valve interstitial cells (VICs), CAVS-prone mice, and humans with subclinical aortic valve
disease all demonstrate a propensity for propagation of injury in valve tissue, even after the initiating cause is
rectified. The goals of this proposal are understand mechanisms, and to identify therapeutic strategies with the
potential to inhibit or reverse propagation of injury in valve tissue. Early aortic valve disease entails thickening
and stiffening of valve cusps, and disruption of laminar shear at the blood-valve interface. The proposal will
address the hypothesis that tissue responses to altered mechanical forces may propagate a pattern of injury in
the aortic valve. Therefore, experiments proposed for Aim 1 will study modulation of signaling by the
mechano-responsive calcium channel, TRPV4, as a means to inhibit propagation of injury. In other disease
states, persistent tissue injury is characterized by sustained actions of mediators of inflammation, which may
be amenable to inhibition by specialized pro-resolving mediators (SPMs). New preliminary data indicate that
two SPMs are expressed in aortic valve cells, and that their expression is altered by CAVS-relevant conditions.
Experiments proposed for Aim 2 will study the impact of modulation of those two SPMs, annexin A1 and
chemokine-like receptor-1, upon propagation of injury in aortic valve cells. Both Aims will be pursued using
VICs grown on matrix with mechanical properties that can be manipulated to resemble properties of aortic
valves. Both Aims will be pursued using a mouse model that consistently develops CAVS, and which reaches
a state where amelioration of the initiating cause of CAVS no longer inhibits disease progression. These new
areas of research in aortic valve disease hold promise for translation to effective therapies for CAVS.
项目概要
钙化性主动脉瓣狭窄(CAVS)可被视为瓣膜长期持续性损伤的终末期
组织。离体瓣膜间质细胞 (VIC)、易发生 CAVS 的小鼠和患有亚临床主动脉瓣的人类
所有疾病都表现出瓣膜组织损伤传播的倾向,即使在引发原因已确定之后也是如此。
已纠正。该提案的目标是了解机制,并确定治疗策略
抑制或逆转瓣膜组织损伤传播的潜力。早期主动脉瓣疾病导致增厚
瓣膜尖端变硬,以及血液-瓣膜界面层流剪切力的破坏。该提案将
解决了组织对改变的机械力的反应可能会传播损伤模式的假设
主动脉瓣。因此,为目标 1 提出的实验将研究信号的调制
机械响应钙通道 TRPV4 作为抑制损伤传播的手段。在其他疾病中
指出,持续性组织损伤的特点是炎症介质的持续作用,这可能
易于被专门的促解析介质 (SPM) 抑制。新的初步数据表明
两种 SPM 在主动脉瓣细胞中表达,并且它们的表达会因 CAVS 相关条件而改变。
为目标 2 提出的实验将研究这两个 SPM、膜联蛋白 A1 和
主动脉瓣细胞损伤传播后的趋化因子样受体-1。这两个目标都将通过使用来实现
VIC 生长在具有机械特性的基质上,可以进行操作以模拟主动脉的特性
阀门。这两个目标都将通过使用持续开发 CAVS 的小鼠模型来实现,并且达到
CAVS 起始原因的改善不再抑制疾病进展的状态。这些新
主动脉瓣疾病的研究领域有望转化为 CAVS 的有效疗法。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Calcium Signaling Regulates Valvular Interstitial Cell Alignment and Myofibroblast Activation in Fast-Relaxing Boronate Hydrogels.
- DOI:10.1002/mabi.202000268
- 发表时间:2020-12
- 期刊:
- 影响因子:4.6
- 作者:Ma H;Macdougall LJ;GonzalezRodriguez A;Schroeder ME;Batan D;Weiss RM;Anseth KS
- 通讯作者:Anseth KS
Acute effects of euglycemic-hyperinsulinemia on myocardial contractility in male mice.
- DOI:10.14814/phy2.15388
- 发表时间:2022-09
- 期刊:
- 影响因子:2.5
- 作者:
- 通讯作者:
Inflammatory serum factors from aortic valve stenosis patients modulate sex differences in valvular myofibroblast activation and osteoblast-like differentiation.
- DOI:10.1039/d2bm00844k
- 发表时间:2022-11-08
- 期刊:
- 影响因子:6.6
- 作者:Vogt, Brandon J.;Peters, Douglas K.;Anseth, Kristi S.;Aguado, Brian A.
- 通讯作者:Aguado, Brian A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT M WEISS其他文献
ROBERT M WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT M WEISS', 18)}}的其他基金
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
- 批准号:
10216324 - 财政年份:2018
- 资助金额:
$ 44.36万 - 项目类别:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
- 批准号:
9977238 - 财政年份:2018
- 资助金额:
$ 44.36万 - 项目类别:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
- 批准号:
9762207 - 财政年份:2018
- 资助金额:
$ 44.36万 - 项目类别:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
靶向 siRNA 纳米技术用于膀胱内治疗泌尿系统疾病
- 批准号:
7938678 - 财政年份:2009
- 资助金额:
$ 44.36万 - 项目类别:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
靶向 siRNA 纳米技术用于膀胱内治疗泌尿系统疾病
- 批准号:
7832079 - 财政年份:2009
- 资助金额:
$ 44.36万 - 项目类别:
Encapsulated siRNAs for treatment of urological disease
用于治疗泌尿系统疾病的封装 siRNA
- 批准号:
7481032 - 财政年份:2007
- 资助金额:
$ 44.36万 - 项目类别:
Encapsulated siRNAs for treatment of urological disease
用于治疗泌尿系统疾病的封装 siRNA
- 批准号:
7238990 - 财政年份:2007
- 资助金额:
$ 44.36万 - 项目类别:
相似国自然基金
靶向Annexin A1蛋白预防CAR-T细胞治疗后BCMA阴性多发性骨髓瘤复发的机制研究
- 批准号:82370201
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
Annexin A1通过IFN-γ通路正向调控PD-L1介导肺腺癌免疫逃逸的机制研究
- 批准号:82172716
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
外源性尿酸调控SP1-Annexin a1在大鼠肝性脑病中的保护作用及机制研究
- 批准号:82060128
- 批准年份:2020
- 资助金额:34 万元
- 项目类别:地区科学基金项目
ABCA1介导ANXA1膜/核竞争性转运在视网膜神经节细胞凋亡中的机制研究
- 批准号:31800868
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Annexin A1 调控 Notch1/Smad2/p15 信号轴促进急性髓系白血病细胞增殖的机制研究
- 批准号:81770176
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10528489 - 财政年份:2021
- 资助金额:
$ 44.36万 - 项目类别:
Novel mitochondrial protective properties of annexin A1
膜联蛋白 A1 的新型线粒体保护特性
- 批准号:
10343330 - 财政年份:2021
- 资助金额:
$ 44.36万 - 项目类别:
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10331887 - 财政年份:2021
- 资助金额:
$ 44.36万 - 项目类别:
Study on the role of annexin A1 in the regulation of gonadotropin secretion from the pituitary gland
膜联蛋白A1对垂体促性腺激素分泌调节作用的研究
- 批准号:
21K05964 - 财政年份:2021
- 资助金额:
$ 44.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Harnessing blood clot clearance mechanisms after germinal matrix hemorrhage
利用生发基质出血后的血凝块清除机制
- 批准号:
10203222 - 财政年份:2021
- 资助金额:
$ 44.36万 - 项目类别: